drugset / Trial / NCT05030857

Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects

NCT05030857

Phase 1 Completed 19 enrolled Lakefront Biotherapeutics NV
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to determine the effect of the administration of multiple doses of GLPG4716 on the amount of midazolam (MDZ) that gets into the blood when the two drugs are administered together compared to when midazolam is administered alone. Other objectives of this study are to evaluate the safety and tolerability of GLPG4716 when administered with midazolam and assess the amount of GLPG4716 that gets into the blood when administered with midazolam. This study will also assess the effect of food on the amount of GLPG4716 that gets into the blood.

Timeline

Start
2021-09-08
Primary completion
2021-11-13
Completion
2021-11-13

Drugs

EvaluationDrugModalityDoseRoute
Subject 5-(4-((2S,5S)-5-(4-CHLOROBENZYL)-2-METHYLMORPHOLINO)PIPERIDIN-1-YL)-1H-1,2,4-TRIAZOL-3-AMINE Small molecule Oral
Subject Midazolam Small molecule Oral

Indications

No indication recorded.